HCM News and Press, HUTCHMED (China) Limited From 04/29/22

Chinese President Xi Jinping directed that the government is committed to "deliver its economic growth target and support the healthy growth of internet platform companies." The edict from Xi himself is highly significant. He is committed to leveraging Alibaba and its peers to help me...

Wuhan Binhui Biopharm closed a $47 million Series B financing to support its R&D of oncolytic virus products. Amoy Diagnostics, a Shanghai novel molecular diagnostics company, signed a collaboration agreement to develop companion diagnostics for AstraZeneca drugs. Hangzhou Asc...

Tencent reported a lackluster FQ4 earnings card. However, management offered cautiously optimistic guidance from H2'22. Notably, we think it represented a clear departure from the uncertainty in its previous earnings commentary. As such, we encourage Tencent investors to add expos...

Baidu (NASDAQ:BIDU) said on Thursday that it was "actively exploring possible solutions" after the Securities and Exchange Commission added the Chinese internet giant to a list of companies that could be delisted from U.S. exchanges. "Baidu will continue to comply with applicable laws and reg...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The United States has started implementing the provisions of a new law, the Holding Foreign Companies Accountable Act (HFCAA) which causes the delisting of Chinese companies from American stock exchanges if their audit reco...

Weibo (NASDAQ:WB) shares plunged sharply in mid-day trading on Wednesday after the Securities and Exchange Commission added the Chinese tech company to the list of companies on its Holding Foreign Companies Accountable Act. Shares of Weibo, which is akin to Twitter, fell more than 3...

Alibaba announced a new massive $25B stock buyback program. It replaced its previous $15B authorization. After last week's massive capitulation in Chinese tech stocks, China has also been following up with policy adjustments. We discuss why we revised our rating on BABA stock to S...

It has been a turbulent ride for NIO this year, especially over the past week as Chinese stocks experienced both the worst sell-off and biggest jump since 2008. Earlier this week, NIO posted sharp multi-day plunges following renewed concerns over delisting and regulatory risks. Th...

Chinese stocks have experienced the worst sell-off since the 2008 global financial crisis. The culmination of geopolitical and COVID-19 risks has created a perfect storm for investors. We discuss how investors should position themselves. For further details see: Chinese ...

Concord, Mass.-based Adiso Therapeutics, an anti-inflammatory biotech, officially emerged from stealth mode with backing from Hong Kong's Morningside Ventures. Morningside has already invested $60 million in the company and has another $35 million earmarked for the company's B round. ...